BIRC5 and malignant glioma: Oncolytic adenovirus type 5, CRAd-Survivin-pk7, was generated by incorporating the survivin promoter to drive E1A gene expression and modification of the fiber protein to contain a poly-lysine (pk7) for enhancing the virus tropism in malignant glioma cells [72].